Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Cash from Financing Activities (2019 - 2025)

Pulmonx has reported Cash from Financing Activities over the past 7 years, most recently at $181000.0 for Q3 2025.

  • Quarterly Cash from Financing Activities fell 60.57% to $181000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $840000.0 through Sep 2025, down 36.27% year-over-year, with the annual reading at $1.4 million for FY2024, 93.63% down from the prior year.
  • Cash from Financing Activities was $181000.0 for Q3 2025 at Pulmonx, up from -$67000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $20.7 million in Q1 2023 and troughed at -$67000.0 in Q2 2025.
  • The 5-year median for Cash from Financing Activities is $181000.0 (2025), against an average of $1.6 million.
  • Year-over-year, Cash from Financing Activities skyrocketed 10015.38% in 2022 and then crashed 204.55% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $150000.0 in 2021, then plummeted by 55.33% to $67000.0 in 2022, then plummeted by 74.63% to $17000.0 in 2023, then soared by 264.71% to $62000.0 in 2024, then surged by 191.94% to $181000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Cash from Financing Activities are $181000.0 (Q3 2025), -$67000.0 (Q2 2025), and $664000.0 (Q1 2025).